Potential of nanoparticulate carriers for improved drug delivery via skin
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Alam Zeb | - |
dc.contributor.author | Sadia Tabassam Arif | - |
dc.contributor.author | Maimoona Malik | - |
dc.contributor.author | Fawad Ali Shah | - |
dc.contributor.author | Fakhar Ud Din | - |
dc.contributor.author | Omer Salman Qureshi | - |
dc.contributor.author | Eun-Sun Lee | - |
dc.contributor.author | Gwan-Yeong Lee | - |
dc.contributor.author | Jin-Ki Kim | - |
dc.date.accessioned | 2021-06-22T11:02:11Z | - |
dc.date.available | 2021-06-22T11:02:11Z | - |
dc.date.issued | 2019-12 | - |
dc.identifier.issn | 2093-5552 | - |
dc.identifier.issn | 2093-6214 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/erica/handle/2021.sw.erica/4611 | - |
dc.description.abstract | Skin as a delivery route for drugs has attracted a great attention in recent decades as it avoids many of the limitations of oral and parenteral administration. However, the excellent barrier property of skin is a major obstacle in the effective transport of drugs through this route. The topmost layer of skin, the “stratum corneum” is the tightest one and is responsible for most of the resistance offered. This necessitates breaching the resistance of the stratum corneum reversibly and transiently in order to achieve a therapeutically meaningful level in systemic circulation or local skin. In last few decades, a number of approaches have been developed to improve the limited drug permeability through stratum corneum. One promising approach is the use of nanoparticulate carriers as they not only facilitate drug delivery across skin but also avoid the drawbacks of conventional skin formulations. This review focuses on nanoparticulate carriers including conventional liposomes, deformable liposomes, ethosomes, niosomes and lipid nanoparticles developed for topical and transdermal drug delivery. A special emphasis is placed on their composition, structure, mechanism of penetration and recent application. The presented data demonstrate the potential of these nanoparticulate carriers for dermal and transdermal delivery. © 2018, The Korean Society of Pharmaceutical Sciences and Technology. | - |
dc.format.extent | 33 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | Springer Netherlands | - |
dc.title | Potential of nanoparticulate carriers for improved drug delivery via skin | - |
dc.type | Article | - |
dc.publisher.location | 미국 | - |
dc.identifier.doi | 10.1007/s40005-018-00418-8 | - |
dc.identifier.scopusid | 2-s2.0-85066798956 | - |
dc.identifier.bibliographicCitation | Journal of Pharmaceutical Investigation, v.49, no.5, pp 485 - 517 | - |
dc.citation.title | Journal of Pharmaceutical Investigation | - |
dc.citation.volume | 49 | - |
dc.citation.number | 5 | - |
dc.citation.startPage | 485 | - |
dc.citation.endPage | 517 | - |
dc.type.docType | Review | - |
dc.identifier.kciid | ART002503378 | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.subject.keywordPlus | 4 methoxycinnamic acid 2 ethylhexyl ester | - |
dc.subject.keywordPlus | aciclovir derivative | - |
dc.subject.keywordPlus | acyclovir palmitate | - |
dc.subject.keywordPlus | alpha tocopherol | - |
dc.subject.keywordPlus | aminolevulinic acid | - |
dc.subject.keywordPlus | benzoyl peroxide | - |
dc.subject.keywordPlus | betamethasone | - |
dc.subject.keywordPlus | cyclosporine | - |
dc.subject.keywordPlus | diclofenac | - |
dc.subject.keywordPlus | ethosome | - |
dc.subject.keywordPlus | glycyrrhizic acid | - |
dc.subject.keywordPlus | griseofulvin | - |
dc.subject.keywordPlus | indometacin | - |
dc.subject.keywordPlus | lamivudine | - |
dc.subject.keywordPlus | liposome | - |
dc.subject.keywordPlus | melatonin | - |
dc.subject.keywordPlus | methotrexate | - |
dc.subject.keywordPlus | nanoparticle | - |
dc.subject.keywordPlus | niosome | - |
dc.subject.keywordPlus | paclitaxel | - |
dc.subject.keywordPlus | paromomycin | - |
dc.subject.keywordPlus | pentoxifylline | - |
dc.subject.keywordPlus | propranolol | - |
dc.subject.keywordPlus | psoralen | - |
dc.subject.keywordPlus | retinoic acid | - |
dc.subject.keywordPlus | retinol | - |
dc.subject.keywordPlus | rutoside | - |
dc.subject.keywordPlus | transfenac | - |
dc.subject.keywordPlus | triamcinolone acetonide | - |
dc.subject.keywordPlus | trihexyphenidyl | - |
dc.subject.keywordPlus | unclassified drug | - |
dc.subject.keywordPlus | unindexed drug | - |
dc.subject.keywordPlus | drug delivery system | - |
dc.subject.keywordPlus | drug penetration | - |
dc.subject.keywordPlus | drug transport | - |
dc.subject.keywordPlus | human | - |
dc.subject.keywordPlus | keratinocyte | - |
dc.subject.keywordPlus | nanotechnology | - |
dc.subject.keywordPlus | parenteral drug administration | - |
dc.subject.keywordPlus | physical chemistry | - |
dc.subject.keywordPlus | priority journal | - |
dc.subject.keywordPlus | Review | - |
dc.subject.keywordPlus | skin | - |
dc.subject.keywordPlus | skin structure | - |
dc.subject.keywordPlus | stratum corneum | - |
dc.subject.keywordPlus | transdermal drug administration | - |
dc.subject.keywordAuthor | Deformable liposomes | - |
dc.subject.keywordAuthor | Ethosomes | - |
dc.subject.keywordAuthor | Lipid nanoparticles | - |
dc.subject.keywordAuthor | Liposomes | - |
dc.subject.keywordAuthor | Nanoparticulate carriers | - |
dc.subject.keywordAuthor | Niosomes | - |
dc.subject.keywordAuthor | Skin permeation | - |
dc.identifier.url | https://link.springer.com/article/10.1007%2Fs40005-018-00418-8 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
55 Hanyangdeahak-ro, Sangnok-gu, Ansan, Gyeonggi-do, 15588, Korea+82-31-400-4269 sweetbrain@hanyang.ac.kr
COPYRIGHT © 2021 HANYANG UNIVERSITY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.